Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 539125 of 542236 entries
View as:

Adaptation Plan for Culturally Competent Care (PAACI) in the Acute Psychiatric Unit.

Phase: N/A Priority: Normal
NCT ID: NCT06879093 Org: User:
Start: 01/01/23 End: 12/31/25 Due: 12/31/26

Thromboelastography to Study Burn Coagulopathy

Phase: N/A Priority: Normal
NCT ID: NCT06879509 Org: User:
Start: 06/30/25 End: 08/31/25 Due: 08/31/26

Risk Factors for Inadequate Bowel Preparation Before Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06878378 Org: User:
Start: 02/21/25 End: 02/01/26 Due: 02/01/27

Observational Study to Evaluate the STALIF® C FLX, STALIF® M FLX, STALIF® L FLX Cages and FORTOS-C®

Phase: N/A Priority: Normal
NCT ID: NCT06876311 Org: User:
Start: 03/04/25 End: 05/30/25 Due: 05/30/26

The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods

Phase: N/A Priority: Normal
NCT ID: NCT06876805 Org: User:
Start: 08/01/24 End: 04/01/27 Due: 04/01/28

Pressure Wire Guidance for Infrapopliteal Artery Interventions

Phase: N/A Priority: Normal
NCT ID: NCT06879561 Org: User:
Start: 03/31/25 End: 08/29/26 Due: 08/29/27

Rebound Pain Following Surgery With Regional Anesthesia Block

Phase: N/A Priority: Normal
NCT ID: NCT05357105 Org: User:
Start: 01/10/23 End: 01/15/25 Due: 01/15/26

A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women

Phase: N/A Priority: Normal
NCT ID: NCT06703060 Org: User:
Start: 02/28/25 End: 02/29/28 Due: 02/28/29

A Multicenter, Randomized, Controlled,Open Label, Phase II Trial of Autologous Tumor Infiltrating Lymphocytes (GC101 TIL) in Subjects With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06703398 Org: User:
Start: 12/20/24 End: 12/20/26 Due: 12/20/27

Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04976855 Org: User:
Start: 08/17/22 End: 07/05/23 Due: 07/05/24

Safer Food Allergy Management for Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT03284372 Org: User:
Start: 01/18/18 End: 07/31/20 Due: 07/31/21

Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

Phase: N/A Priority: Normal
NCT ID: NCT06879925 Org: User:
Start: 12/02/24 End: 04/07/25 Due: 04/07/26

Effects of Thoracic Mobility Exercises in Geriatric Individuals

Phase: N/A Priority: Normal
NCT ID: NCT06876922 Org: User:
Start: 01/10/24 End: 06/12/24 Due: 06/12/25

Osteosclerotic Changes on CT Predict Survival in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06883474 Org: User:
Start: 07/01/10 End: 05/30/23 Due: 05/30/24

An Exploratory Clinical Study on Neoadjuvant Treatment of Hepatocellular Carcinoma with QL1706 Combined with Lenvatinib

Phase: N/A Priority: Normal
NCT ID: NCT06884982 Org: User:
Start: 03/13/25 End: 09/30/28 Due: 09/30/29

Pedaling at a Low-Moderate Intensity During Chemotherapy Administration

Phase: N/A Priority: Normal
NCT ID: NCT04258969 Org: User:
Start: 01/11/20 End: 10/14/21 Due: 10/14/22

Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)

Phase: N/A Priority: Normal
NCT ID: NCT00103922 Org: User:
Start: 11/30/04 End: 01/31/07 Due: 01/31/08

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Phase: N/A Priority: Normal
NCT ID: NCT01966419 Org: User:
Start: 01/07/14 End: 12/29/16 Due: 12/29/17

hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00285194 Org: User:
Start: 04/30/00 End: 01/31/04 Due: 01/31/05

Risk Stratification Care for Injury Prevention in Taiwan Adolescent Baseball Players

Phase: N/A Priority: Normal
NCT ID: NCT06637241 Org: User:
Start: 10/14/24 End: 08/31/25 Due: 08/31/26

RRT With a Cytokine Absorption Filter (oXiris ®) in Patients With Septic Shock

Phase: N/A Priority: Normal
NCT ID: NCT04952714 Org: User:
Start: 09/01/21 End: 11/10/23 Due: 11/10/24

VR Homework Exercises for Selective Mutism Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06882629 Org: User:
Start: 03/31/25 End: 06/30/27 Due: 06/30/28

Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD

Phase: N/A Priority: Normal
NCT ID: NCT06883266 Org: User:
Start: 11/11/24 End: 12/11/26 Due: 12/11/27

The Effects of Exercise on Quality of Life and Fluid Dynamics in Patients With Aortic Dissection

Phase: N/A Priority: Normal
NCT ID: NCT05499650 Org: User:
Start: 10/04/21 End: 05/31/24 Due: 05/31/25

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06048718 Org: User:
Start: 06/05/24 End: 07/31/26 Due: 07/31/27